Published Online
on June 29, 2009

A more recent version of this article appeared on July 14, 2009

This Article Full Text (PDF) All Versions of this Article: 120/2/101    most recent CIRCULATIONAHA.109.872473v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Drachman, D. E. PubMed PubMed Citation Articles by Drachman, D. E. Related Collections Restenosis Animal models of human disease Arterial thrombosis Catheter-based coronary and valvular interventions: other Related Article

Submitted on ,
Accepted on ,

Drug-Eluting Stents in Animals and Patients. Where Do We Stand Today?

Douglas E. Drachman MD^*

From the Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston.

^* To whom correspondence should be addressed. E-mail: ddrachman{at}partners.org.

Key words: Editorials • animal model • paclitaxel • restenosis • sirolimus • stents • thrombosis

Related Article:

Comparison of Inflammatory Response After Implantation of Sirolimus- and Paclitaxel-Eluting Stents in Porcine Coronary Arteries

Gregory J. Wilson, Gaku Nakazawa, Robert S. Schwartz, Barbara Huibregtse, Bradley Poff, Thomas J. Herbst, Donald S. Baim, and Renu Virmani
Circulation 2009 120: 141-149. [Abstract] [Full Text]